Partnervest Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Partnervest Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,320	Closed	-$256K	–	207
2017 Q2	$256K	Sell	3,320 -21	-0.6%	-$1.49K	0.12%	163
2017 Q1	$232K	Buy	+3,341	New	+$224K	0.1%	171
2016 Q4	–	Sell	-4,809	Closed	-$319K	–	213
2016 Q3	$319K	Sell	4,809 -1,000	-17%	-$61.9K	0.15%	149
2016 Q2	$314K	Buy	+5,809	New	+$318K	0.16%	143
2014 Q3	–	Sell	-753	Closed	-$39K	–	816
2014 Q2	$39K	Hold	753	–	–	0.02%	416
2014 Q1	$36K	Buy	753 +3	+0.4%	+$154	0.02%	393
2013 Q4	$33K	Hold	750	–	–	0.02%	386
2013 Q3	$32K	Hold	750	–	–	0.02%	356
2013 Q2	$26K	Buy	+750	New	+$26.4K	0.01%	365

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Partnervest Advisory Services's XBI Position: Q3 2017 in Review

Partnervest Advisory Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2017, closing a stake of 3,320 shares — an estimated $256K sold.

Partnervest Advisory Services first reported a position in XBI in Q2 2013 and held it in 9 quarters. The position peaked at $319K in Q3 2016. 349 funds tracked by Wall St. Rank hold XBI as of Q3 2017.

Partnervest Advisory Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2017 after selling out during the quarter.
Partnervest Advisory Services sold 3,320 State Street SPDR S&P Biotech ETF shares in Q3 2017, an estimated $256K.
Partnervest Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 9 quarters.
Partnervest Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $319K in Q3 2016.
349 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2017.

Based on Partnervest Advisory Services's 13F filing for Q3 2017, filed 13 Nov 2017.